Trending...
- Wealthywet's Miami Swim Week 2025 Debut Signals a New Era of Luxury in Swimwear
- BREAKING CONSUMER ALERT: Carvana's "Certified" Luxury SUV Buyer Exposes Legal & Mechanical Trauma 'Presses' Charges of Duress, Deception, and Delay
- Boston Saves Provides Financial Boost to BPS Students, Setting them up Future Success
CAMBRIDGE, Mass. ~ Seres Therapeutics, Inc. (Nasdaq: MCRB) announced on April 5, 2023 that the Compensation and Talent Committee of its board of directors granted inducement equity grants to three new employees. The grants consist of stock options to purchase 11,000 shares of common stock and restricted stock units (RSUs) covering an aggregate of 11,000 shares of its common stock.
The grants are subject to the terms of the Seres Therapeutics, Inc. 2022 Employment Inducement Award Plan (the "Inducement Plan"). The Inducement Plan was adopted by Seres' board of directors in December 2022 and is used exclusively for the grant of equity awards to individuals as an inducement material to their entering into employment with Seres pursuant to Nasdaq Listing Rule 5635(c)(4).
More on Boston Chron
The stock options have an exercise price of $5.61 per share and will vest as to 25% of the total number of shares subject to the option on the first anniversary of the applicable individual's date of hire and as to 6.25% of the total number of shares subject to the option upon a completion of each three full months of service to the Company thereafter. The RSUs vest as to 25% on the first 15th day after a calendar month that immediately follows the first anniversary date and as to an additional 6.25% upon completion each three full months thereafter.
Seres Therapeutics is a leading microbiome therapeutics company that is committed to providing innovative treatments for patients with serious diseases.
The grants are subject to the terms of the Seres Therapeutics, Inc. 2022 Employment Inducement Award Plan (the "Inducement Plan"). The Inducement Plan was adopted by Seres' board of directors in December 2022 and is used exclusively for the grant of equity awards to individuals as an inducement material to their entering into employment with Seres pursuant to Nasdaq Listing Rule 5635(c)(4).
More on Boston Chron
- DivX Enhances AVI Playback Resources; Simplifies Guide to Playing AVI Files with DivX Software
- Patrick Aloni Joins Historic Gold and Copper Discovery in Argentina with Multimillion-Dollar Stake
- Boston: June is Men's Mental Health Awareness Month
- Boston: Happy Juneteenth!
- Boston: Council Denounces Renaming of Navy Ships
The stock options have an exercise price of $5.61 per share and will vest as to 25% of the total number of shares subject to the option on the first anniversary of the applicable individual's date of hire and as to 6.25% of the total number of shares subject to the option upon a completion of each three full months of service to the Company thereafter. The RSUs vest as to 25% on the first 15th day after a calendar month that immediately follows the first anniversary date and as to an additional 6.25% upon completion each three full months thereafter.
Seres Therapeutics is a leading microbiome therapeutics company that is committed to providing innovative treatments for patients with serious diseases.
Filed Under: Business
0 Comments
Latest on Boston Chron
- South Shore Food Bank's Epic FOOD FIGHT Fundraiser Set for June 21st
- United States Congressional Candidate Peter Coe Verbica Unveils 25-Point Federal Plan to Help Make California Affordable Again
- D8Averse Launches D8Acapture: Disruptive Mobile-First App Transforms Utility Pole Data Collection
- 2025 Romance Travel Forum Drives Targeted Growth and Industry Collaboration
- Experience Trembling Firsthand with the New AgeMan® Tremor Simulator
- Mauro Schnaidman named as Managing Director in Miami, Florida
- Continued Streak of Recognitions with Multiple Chambers and Partners Rankings
- Anern Shines at SOLAR AFRICA Kenya with Solar Lithium Battery Storage Technology
- Last Call - Submit Your Proposal for the 2025 OpenSSL Conference in Prague
- Robert Michael & Co. Launches New Real Estate Website to Serve Central Florida Homebuyers and Sellers
- IFFA 2025 Shines Bright as Mukesh Modi Welcomes Rio Rocket and Award Winner Lulu Lopez
- Kemeny, Ramp & Renaud Expands Legal Team with Attorney Baruch Kraut
- WOA Entertainment Group Unveils Independent No.1's: Breakthrough Artists II —A Celebration of Indie Excellence
- SheepFeast Launches "1 Million Discipled" Global Initiative to Empower Disciple-Making Around the World
- Sun City Resident Realtor Launches Exclusive Weekly Market Update for Bluffton's 55+ Communities!
- Mythical Man-Fae: A Captivating Adult Coloring Book of Fantasy and Enchantment
- Delta Capital Group, Inc. Earns A+ Rating from the Better Business Bureau, Marking Another Milestone in Explosive Growth
- Mayor Michelle Wu and Office of Youth Engagement and Advancement Celebrate 30 Years of Boston Mayor's Youth Council
- Vice President JD Vance & Industry Leaders at Bitcoin Conference After Partnership Signing to Optimize Cybersecurity Solutions: Bullet Blockchain, Inc
- Actress/Comedian Schelle Purcell Sizzles This Summer with Star-Making Turn in Tyler Perry's #1 Netflix Film, Straw, and Upcoming Comedy Special